Practice guideline for lipodystrophy syndromes-clinically important diseases of the Japan Endocrine Society (JES).,Endocrine Journal

当前位置： X-MOL 学术 › Endocr. J. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Practice guideline for lipodystrophy syndromes-clinically important diseases of the Japan Endocrine Society (JES).
Endocrine Journal ( IF 2 ) Pub Date : 2021-08-07 , DOI: 10.1507/endocrj.ej21-0110
Tomohiro Tanaka _{1,

2} , Toru Kusakabe _{1,

3} , Ken Ebihara ₄ , Megumi Aizawa-Abe ₅ , Daisuke Aotani _{1,

2} , Tohru Yorifuji ₆ , Mari Satoh ₇ , Yoshihiro Ogawa _{8,

9} , Kazuwa Nakao ₁

Affiliation

Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.
Department of Gastroenterology and Metabolism, Graduate School of Medical Sciences and Medical School, Nagoya City University, Nagoya 467-8601, Japan.
National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Jichi Medical University, Tochigi 329-0431, Japan.
Tazuke Kofukai, Medical Research Institute, Kitano Hospital, Osaka 530-8480, Japan.
Pediatric Endocrinology and Metabolism, Osaka City General Hospital, Osaka 534-0021, Japan.
Pediatrics Center, Toho University Omori Medical Center, Tokyo 143-8540, Japan.
Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 821-8582, Japan.
Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.